FAM
Fred Alger Management Portfolio holdings
AUM
$22.3B
1-Year Return
57.87%
This Quarter Return
+12.43%
1 Year Return
+57.87%
3 Year Return
+264.72%
5 Year Return
+406.03%
10 Year Return
+1,631.73%
AUM
$27.2B
AUM Growth
+$1.69B
(+6.6%)
Cap. Flow
-$815M
Cap. Flow
% of AUM
-3%
Top 10 Holdings %
Top 10 Hldgs %
35.28%
Holding
550
New
72
Increased
170
Reduced
177
Closed
71
Top Buys
| 1 |
UnitedHealth
UNH
|
$170M |
| 2 |
JPMorgan Chase
JPM
|
$131M |
| 3 |
Qualcomm
QCOM
|
$121M |
| 4 |
Fiserv
FI
|
$110M |
| 5 |
VeriSign
VRSN
|
$110M |
Top Sells
| 1 |
Amazon
AMZN
|
$393M |
| 2 |
Microsoft
MSFT
|
$306M |
| 3 |
Abbott
ABT
|
$163M |
| 4 |
Home Depot
HD
|
$161M |
| 5 |
AGN
Allergan plc
AGN
|
$146M |
Sector Composition
| 1 | Technology | 32.58% |
| 2 | Healthcare | 21.35% |
| 3 | Consumer Discretionary | 13.11% |
| 4 | Financials | 10.29% |
| 5 | Communication Services | 9.89% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
326
Halozyme
HALO
$8.76B
| $1.17M | ﹤0.01% |
66,000
| – | – |
|
327
Welltower
WELL
$112B
| $1.17M | ﹤0.01% |
14,308
-113,445
| -89% | -$9.28M |
|
328
Tyson Foods
TSN
$20B
| $1.15M | ﹤0.01% |
12,668
-391
| -3% | -$35.6K |
|
329
General Dynamics
GD
$86.8B
| $1.14M | ﹤0.01% |
6,434
-1,984
| -24% | -$350K |
|
|
DCPH
330
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
| $1.12M | ﹤0.01% |
+18,000
| New | +$1.12M |
|
331
CDW
CDW
$22.2B
| $1.09M | ﹤0.01% |
7,656
+7,515
| +5,330% | +$1.07M |
|
|
SAGE
332
DELISTED
Sage Therapeutics
SAGE
| $1.08M | ﹤0.01% |
15,000
+7,500
| +100% | +$542K |
|
333
Cheniere Energy
CQP
$26.1B
| $1.08M | ﹤0.01% |
27,028
| – | – |
|
334
Royal Caribbean
RCL
$95.7B
| $1.06M | ﹤0.01% |
7,955
| – | – |
|
335
Americold
COLD
$3.98B
| $1.06M | ﹤0.01% |
30,242
-55,476
| -65% | -$1.94M |
|
336
GeoPark
GPRK
$326M
| $1.05M | ﹤0.01% |
47,629
+16,064
| +51% | +$353K |
|
|
SPLK
337
DELISTED
Splunk Inc
SPLK
| $1.04M | ﹤0.01% |
+6,937
| New | +$1.04M |
|
338
Tapestry
TPR
$21.7B
| $1.03M | ﹤0.01% |
38,311
| – | – |
|
339
MKS Inc. Common Stock
MKSI
$7.02B
| $1.02M | ﹤0.01% |
+9,303
| New | +$1.02M |
|
340
Kohl's
KSS
$1.86B
| $1.02M | ﹤0.01% |
20,021
| – | – |
|
341
Zymeworks
ZYME
$1.14B
| $1M | ﹤0.01% |
+22,000
| New | +$1M |
|
342
Afya
AFYA
$1.37B
| $997K | ﹤0.01% |
36,753
+8,000
| +28% | +$217K |
|
|
CONE
343
DELISTED
CyrusOne Inc Common Stock
CONE
| $988K | ﹤0.01% |
15,093
-3,710
| -20% | -$243K |
|
344
FibroGen
FGEN
$48.9M
| $986K | ﹤0.01% |
920
| – | – |
|
|
IMMU
345
DELISTED
Immunomedics Inc
IMMU
| $973K | ﹤0.01% |
46,000
+3,000
| +7% | +$63.5K |
|
346
Gilead Sciences
GILD
$143B
| $961K | ﹤0.01% |
14,783
| – | – |
|
347
Aurinia Pharmaceuticals
AUPH
$1.63B
| $952K | ﹤0.01% |
+47,000
| New | +$952K |
|
348
Fate Therapeutics
FATE
$116M
| $939K | ﹤0.01% |
48,000
+8,000
| +20% | +$157K |
|
349
BioMarin Pharmaceuticals
BMRN
$11.1B
| $936K | ﹤0.01% |
11,070
+4,314
| +64% | +$365K |
|
350
Equinix
EQIX
$75.7B
| $915K | ﹤0.01% |
1,567
| – | – |
|